| Descriptor English: | Dinoprost | ||||||
| Descriptor Spanish: | 
                                Dinoprost                                        
                                        
                                                                                                                            
                                            
  | ||||||
| Descriptor Portuguese: | Dinoprosta | ||||||
| Descriptor French: | Dinoprost | ||||||
| Entry term(s): | 
                                    9alpha,11beta PGF2 9alpha,11beta-PGF2 Enzaprost F Estrofan F2 alpha, Prostaglandin F2alpha, Prostaglandin PGF2 PGF2 alpha PGF2alpha Prostaglandin F2 Prostaglandin F2 alpha Prostaglandin F2alpha alpha, PGF2  | 
                                            ||||||
| Tree number(s): | 
                                        D10.251.355.255.550.400.200 D23.469.050.175.725.400.200  | 
                                ||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015237 | ||||||
| Scope note: | A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. | 
                                    ||||||
| Annotation: | do not confuse with DINOPROSTONE; /biosyn /physiol permitted | 
                                    ||||||
| Allowable Qualifiers: | 
                                                                        AA                                                            analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine  | 
                                            ||||||
| Pharm Action: | 
                                                                                                    Abortifacient Agents, Nonsteroidal Oxytocics  | 
                                    ||||||
| Registry Number: | B7IN85G1HY | ||||||
| CAS Type 1 Name: | Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)- | ||||||
| Previous Indexing: | 
                                                Prostaglandins (1966-1974) Prostaglandins F (1975-1988)  | 
                                        ||||||
| Public MeSH Note: | 89 | 
                                                ||||||
| History Note: | 89 | 
                                                ||||||
| Related: | 
                                                                                                                        F2-Isoprostanes
                                            MeSH                                             | ||||||
| DeCS ID: | 23609 | ||||||
| Unique ID: | D015237 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1989/01/01 | ||||||
| Date of Entry: | 1988/05/14 | ||||||
| Revision Date: | 2015/06/08 | 
- 
                                    
- 
                                        CHEMICALS AND DRUGS
 
Lipids [D10]Lipids - 
                                    
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors 
| 
                                                             | 
                                
                        
                                                                    
                        Dinoprost                                            
                                        - Preferred                                        
                                                                
                                
                        
                        
                        
                                                                    
                        Estrofan                                            
                                        - Narrower                                        
                                                                
                                
                                                                    
                        Enzaprost F                                            
                                        - Narrower                                        
                                                                
                                
                        
                        
                    
                    
                
                | Concept UI | 
                                        
                                        M0023416 | 
                                
| Scope note | A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. | 
| Preferred term | Dinoprost | 
| Entry term(s) | 
                                        
                                                                                            9alpha,11beta PGF2                                                 9alpha,11beta-PGF2 F2 alpha, Prostaglandin F2alpha, Prostaglandin PGF2 PGF2 alpha PGF2alpha Prostaglandin F2 Prostaglandin F2 alpha Prostaglandin F2alpha alpha, PGF2  | 
                                
| Concept UI | 
                                        
                                        M0023418 | 
                                
| Preferred term | Estrofan | 
| Concept UI | 
                                        
                                        M0023417 | 
                                
| Preferred term | Enzaprost F | 
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey